אנסטרוזול מדיטק 1 מ"ג

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

ANASTROZOLE 1 MG

Disponible desde:

SAM-ON LTD

Código ATC:

L02BG03

formulario farmacéutico:

FILM COATED TABLETS

Vía de administración:

PER OS

Fabricado por:

HELM PHARMACEUTICALS GMBH, GERMANY

Grupo terapéutico:

ANASTROZOLE

indicaciones terapéuticas:

Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

Fecha de autorización:

2011-01-01